Prime Medicine, Inc.
PRME
$3.69
$0.13883.91%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -199.28M | -202.01M | -195.88M | -219.25M | -217.44M |
| Total Depreciation and Amortization | 6.84M | 6.51M | 6.13M | 5.66M | 5.34M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 33.67M | 37.95M | 35.81M | 33.95M | 33.89M |
| Change in Net Operating Assets | 58.83M | 53.53M | 31.08M | -3.33M | -18.01M |
| Cash from Operations | -99.94M | -104.02M | -122.87M | -182.97M | -196.23M |
| Capital Expenditure | -7.06M | -7.39M | -7.29M | -7.34M | -8.98M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 60.69M | 65.14M | 75.75M | 68.83M | -17.65M |
| Cash from Investing | 53.62M | 57.75M | 68.46M | 61.49M | -26.62M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 38.71M | 38.55M | 171.08M | 171.27M | 133.07M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 6.00M | 6.00M | 24.80M | 24.80M | 24.80M |
| Cash from Financing | 44.71M | 44.55M | 195.88M | 196.07M | 157.87M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.60M | -1.72M | 141.47M | 74.58M | -64.98M |